Pixium Vision announces presentations of current clinical data with PRIMA implant during the American Academy of Ophthalmology annual congressadmin2019-09-11T17:31:47+02:00October 23rd, 2018|
Pixium Vision announces positive review of the first results with PRIMA, its wireless subretinal implant, in patients with atrophic Dry-AMDadmin2019-09-11T17:31:49+02:00September 24th, 2018|
Pixium Vision announces the presentation of the first clinical results with PRIMA, its wireless implant, in patients with atrophic Dry-AMDadmin2019-09-11T17:31:49+02:00September 18th, 2018|
Pixium Vision achieves successful activation of its photovoltaic PRIMA implant in all five study patients with Dry Age-related Macular Degenerationadmin2019-09-11T17:31:49+02:00August 30th, 2018|
Pixium Vision restructures its bond financing facility with Kreos Capitaladmin2019-09-11T17:31:50+02:00August 1st, 2018|
Pixium Vision announces H1 2018 financial results and provides an update on its activitiesadmin2019-09-11T17:31:50+02:00July 26th, 2018|
Pixium Vision completes implantation of PRIMA in five patients with atrophic dry-AMD as expected for the feasibility clinical trial in Franceadmin2019-09-11T17:31:50+02:00July 10th, 2018|
Annual General Meeting and Board of Directors of June 27, 2018admin2019-09-11T17:31:51+02:00June 27th, 2018|
Pixium Vision announces the significant success of its €10.6 million rights issueadmin2019-09-11T17:31:52+02:00May 3rd, 2018|
Pixium Vision’s research partner, Stanford University, to present advances on bioelectronic PRIMA platform technology during ARVO 2018admin2019-09-11T17:31:56+02:00April 27th, 2018|
Pixium Vision launches a €10.6 million rights issue to support the advances in clinical development of PRIMA, its breakthrough Bionic Vision Systemadmin2019-09-11T17:31:52+02:00April 11th, 2018|
